• By ICR Secretariat
  • Posted Wednesday, April 10, 2019

Brexit will have ‘minimal’ effect on R&D in UK, says expert


Despite Brexit uncertainties, the future for UK research and development (R&D), specifically clinical trials, is looking promising, heard delegates at the ‘Brexit: What's Next for Pharma?’ Pharmaceutical Industry Network Group (PING) conference in Hatfield, UK, this week.